Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Alpine Pet Opco LLC is currently managing 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This matter is assigned to a distinct examiner and a distinct art unit, creating a highly centralized prosecution environment. With only one active case, the company can focus its legal resources on a single set of patentability issues.
The busiest examiner, PRAGANI, RAJAN, is responsible for the 1 pending office action. Because this examiner is the sole official reviewing the company's current applications, their specific interpretation of the law will determine the immediate success of the portfolio. The lack of examiner diversity means there are no other pending matters to offset a potential rejection from this individual.
Operating within a single art unit allows the applicant to tailor their arguments to the specific culture and guidelines of that unit. Practitioners should prioritize understanding the previous rulings and preferences of PRAGANI, RAJAN to navigate the prosecution process effectively. This concentrated focus minimizes administrative complexity while emphasizing the importance of this individual examiner's perspective.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PRAGANI, RAJAN | 1 | 53.1% | +69.8% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18848152 | EDIBLE SOFT DENTAL CHEW AND METHODS OF USING THE SAME | PRAGANI, RAJAN | — |
| Art Unit | Apps |
|---|---|
| 1614 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18848152 | EDIBLE SOFT DENTAL CHEW AND METHODS OF USING THE SAME | PRAGANI, RAJAN | 1614 | §103§112DP | Non-Final OA | — | Pending | Sep 18, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialAlpine Pet Opco LLC has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Rajan Pragani has the most, with 1 of Alpine Pet Opco LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.